Accrued liabilities as of March 31, 2023 and December 31, 2022 consisted of the following:
March 31,
December 31,
2023
2022
Accrued personnel related costs
$
1,180
2,302
Accrued research and development expenses
5,005
3,122
Other accrued expenses
409
233
Total
6,594
5,657
No definition available.
Tabular disclosure of the components of accrued liabilities.